EUVIMEDEUVIMED entdecken
Crossref

Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing

Hilmi Alnsasra, Radha Kanneganti Perue, Fouad Khalil, Ohad Regev, Sudhir S Kushwaha, Alexandros Briasoulis, Rabea Asleh

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2024.02.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Hilmi Alnsasra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn; Department of Cardiology, Soroka University Medical Center, Beersheva, Israel; F…. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In light of the updated lowered threshold for diagnosing pulmonary hypertension (PH), the reversibility of precapillary PH with left ventricular assist device (LVAD) and the associated post-heart transplantation (HT) outcomes remain unclear. METHODS: Using data from the United Network for Organ Sharing database, we aimed to investigate predictors of persistent precapillary PH in HT recipients bridged with LVAD and examine the interrelated post-HT survival using the updated pulmonary vascular resistance (PVR) cutoff of >2 Wood units for precapillary PH. RESULTS: Among 2169 HT recipients bridged with LVAD, 1299 had PVR >2 at baseline; 551 (42.4%) of whom normalized their PVR ≤2 and 748 (57.6%) remained with elevated PVR >2 after LVAD implantation. Female sex (adjusted odds ratio [aOR]; 2.22, 95% confidence interval [CI], 1.61-3.07; P 2 after LVAD was associated with increased risk of death compared with those who normalized their PVR (adjusted hazard ratio [aHR], 1.26; 95% CI, 1.01-1.57; P = .037). However, the normalized PVR post-LVAD group had comparable survival with those with PVR ≤2 at baseline (aHR, 0.76; 95% CI, 0.57-1.02; P = .07). CONCLUSIONS: Many recipients of HT bridged with LVAD remain with PVR >2 after LVAD implantation, which is associated with increased risk of death after HT compared with patients with normalized PVR after LVAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart TransplantationHypertension, PulmonaryHeart FailureHumansMaleFemaleMiddle AgedTreatment OutcomeAdultVascular ResistanceRetrospective StudiesRisk FactorsUnited StatesTime FactorsDatabases, FactualVentricular Function, LeftPulmonary Artery

Stichwörter der Autor:innen

heart transplantleft ventricular assist devicepulmonary hypertensionpulmonary vascular resistance

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn; Department of Cardiology, Soroka University Medical Center, Beersheva, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beershe…
  • Department of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Neb.
  • Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.
  • Department of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn; Heart Institute, Hadassah University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: rasle…

Zitieren

APA

Alnsasra, H., Perue, R. K., Khalil, F., Regev, O., Kushwaha, S. S., Briasoulis, A., & Asleh, R. (2025). Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.02.022

Vancouver

Alnsasra H, Perue RK, Khalil F, Regev O, Kushwaha SS, Briasoulis A, et al. Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.02.022

BibTeX
@article{Alnsasra2025,
  author = {Alnsasra, Hilmi and Perue, Radha Kanneganti and Khalil, Fouad and Regev, Ohad and Kushwaha, Sudhir S and Briasoulis, Alexandros and Asleh, Rabea},
  title = {Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2024.02.022}
}
Kostenlos starten →